Qiuhe Ji

16PUBLICATIONS
31CO-AUTHORS
Metabolic medicinePredictive and prognostic markersInformation systems development methodologies and practiceMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 03, 2026
Body Mass Index, Cardiometabolic Treatment Patterns and Multifactorial Risk-Factor Control in Chinese Adults With Type 2 Diabetes: A Multicenter Cross-Sectional Study.

|Feb 12, 2026
Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression.

Richard C O'Brien, Khalifa Abdallah, Xuehong Dong

|Oct 27, 2025
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024.

Wenjia Yang, Xiaoling Cai, Qiuhe Ji

|Oct 21, 2023
The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open-label, randomized trial.

Xiangyang Liu, Wenjuan Yang, Jianrong Liu

|Sep 26, 2023
Serum uric acid to high-density lipoprotein cholesterol ratio is a promising marker for identifying metabolic syndrome in nondiabetic Chinese men.

Xinwen Yu, Fei Sun, Jie Ming

|Jun 12, 2023
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study.

Fu Jianfang, Xiao Wanxia, Gao Xiling

Pageof 3

Frequent Collaborators

2 joint publications

Xu Qian

2 joint publications

Shengru Liang

2 joint publications

Yanbing Li

2 joint publications

NanWei Tong